Discovery of a novel quinoline RIP1 inhibitor and its treatment of acute liver injury in mice
- 12 March 2025
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 159, 108365
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82404436)
This publication has 30 references indexed in Scilit:
- Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsyEuropean Journal of Medicinal Chemistry, 2024
- Molecular medicinal insights into scaffold hopping-based drug discovery successDrug Discovery Today, 2023
- Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agentsBioorganic & Medicinal Chemistry, 2023
- Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitorsEuropean Journal of Medicinal Chemistry, 2022
- Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver diseaseJournal of Hepatology, 2020
- Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3Molecular Cell, 2014
- The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch MechanismImmunity, 2013
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 UbiquitinationMolecular Cell, 2008
- The Mode of Death of Pig Kidney Cells Infected with Cowpox Virus Is Governed by the Expression of thecrmAGeneVirology, 1996